Eye injection study for diabetes-related vision loss ends early

NCT ID NCT07228559

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested a single injection of avoralstat into the eye for people with diabetic macular edema, a condition that causes vision loss in diabetes. Only 3 adults took part before the study was stopped early. The main goal was to check safety and see if the drug might help reduce swelling in the retina.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA (DME) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic macular edema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Investigative Site 1

    Sydney, New South Wales, Australia

  • Investigative Site 2

    Sydney, New South Wales, Australia

  • Investigative Site 3

    Sydney, New South Wales, Australia

  • Investigative Site 4

    Adelaide, South Australia, Australia

  • Investigative Site 5

    Melbourne, Victoria, Australia

  • Investigative Site 6

    Sacramento, California, 95825, United States

  • Investigative Site 7

    Katy, Texas, 77494, United States

  • Investigative Site 8

    The Woodlands, Texas, 77384, United States